The diagnosis of interstitial lung disease (ILD) can be difficult, especially in the early stages when pulmonary function tests (PFTs) show only minor changes. To improve the effectiveness of early diagnosis, researchers wanted to evaluate the potential of artificial intelligence (AI)-based software to support pulmonary specialists in analyzing PFT results.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Case study
Orofacial Manifestations of Phelan-McDermid Syndrome
- Atherosclerotic Coronary Plaques in High-Risk Patients
Who benefits from preventive PCI?
- Colorectal Cancer
Insulin Resistance, Obesity, and Progression
- Modern asthma therapies
New data on biologics and triple therapy
- From symptom to diagnosis
Abdominal Pain – Focal Nodular Hyperplasia
- Clinically Suspected Arthralgias
“Watchful waiting” or intervention?
- Hepatology and Metabolism
The Mediterranean Diet for MASLD/MASH—What the EASL-EASD-EASO Guidelines Specifically Recommend
- Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?